top of page
The company has manufactured three patented brands of pharmaceutical for worldwide consumption in China since 2010. We are exiting China as our primary manufacturer and withdrawing our license effective December 31, 2026.
The company needs to be fully equipped in a 200,000 sq ft building. Location to be determined.
The RFP is for a turnkey provider who will be responsible to complete 100% of the project.
Arthur
Rosenfield
Pharmaceutical Manufacturing
bottom of page